Guyana vs Uzbekistan: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Guyana
99.0%
in 2025
Uzbekistan
99.0%
in 2025
Guyana rank
1st
Uzbekistan rank
1st
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Guyana
- Uzbekistan
How they compare
Guyana currently reports 99.0% against 99.0% in Uzbekistan, a difference of 0.0%.
The two have swapped places 6 times across 18 shared years of data; in 2008 it was Uzbekistan ahead.
Guyana ranks 1st and Uzbekistan ranks 1st of 194 countries.
Across the 3 decades both report, Guyana averaged higher in 1 and Uzbekistan in 1.
Head to head by decade
| Decade | Guyana | Uzbekistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 80.5% | 29.4% | 51.1% | Guyana |
| 2020s | 96.2% | 97.0% | 0.8% | Uzbekistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Guyana or Uzbekistan?
- Guyana, at 99.0% against 99.0% in Uzbekistan as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Guyana and Uzbekistan?
- 0.0%, with Guyana ahead.
- How many years of comparable data are there for Guyana and Uzbekistan?
- 18 years are reported by both, from 2008 to 2025.
- How do Guyana and Uzbekistan rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Guyana ranks 1st and Uzbekistan ranks 1st of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.